{"id":"https://openalex.org/W7224673567","doi":"https://doi.org/10.1080/17460441.2026.2749525","title":"Cholinergic-targeted molecular hybrids: a renewed strategy for Alzheimer\u2019s disease?","display_name":"Cholinergic-targeted molecular hybrids: a renewed strategy for Alzheimer\u2019s disease?","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224673567","doi":"https://doi.org/10.1080/17460441.2026.2749525","pmid":"https://pubmed.ncbi.nlm.nih.gov/42953958"},"language":"en","primary_location":{"id":"doi:10.1080/17460441.2026.2749525","doi":"https://doi.org/10.1080/17460441.2026.2749525","is_oa":true,"landing_page_url":"https://doi.org/10.1080/17460441.2026.2749525","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/17460441.2026.2749525?needAccess=true","source":{"id":"https://openalex.org/S142541038","display_name":"Expert Opinion on Drug Discovery","issn_l":"1746-0441","issn":["1746-0441","1746-045X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Discovery","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/17460441.2026.2749525?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5097353868","display_name":"Marco Cerini","orcid":"https://orcid.org/0009-0004-7532-236X","observed_orcids":["https://orcid.org/0009-0004-7532-236X"]},"institutions":[{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Cerini","raw_affiliation_strings":["University of Bari Aldo Moro"],"raw_orcid":"https://orcid.org/0009-0004-7532-236X","affiliations":[{"raw_affiliation_string":"University of Bari Aldo Moro","institution_ids":["https://openalex.org/I5561750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061026541","display_name":"Rosalba Leuci","orcid":"https://orcid.org/0000-0002-5229-988X","observed_orcids":["https://orcid.org/0000-0002-5229-988X"]},"institutions":[{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rosalba Leuci","raw_affiliation_strings":["University of Bari Aldo Moro"],"raw_orcid":"https://orcid.org/0000-0002-5229-988X","affiliations":[{"raw_affiliation_string":"University of Bari Aldo Moro","institution_ids":["https://openalex.org/I5561750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109758702","display_name":"Marco Paparella","orcid":"https://orcid.org/0009-0000-9744-3606","observed_orcids":["https://orcid.org/0009-0000-9744-3606"]},"institutions":[{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Paparella","raw_affiliation_strings":["University of Bari Aldo Moro"],"raw_orcid":"https://orcid.org/0009-0000-9744-3606","affiliations":[{"raw_affiliation_string":"University of Bari Aldo Moro","institution_ids":["https://openalex.org/I5561750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063275568","display_name":"Vincenzo Roselli","orcid":"https://orcid.org/0009-0007-2910-9359","observed_orcids":["https://orcid.org/0009-0007-2910-9359","https://orcid.org/0000-0002-5412-8136"]},"institutions":[{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vincenzo Roselli","raw_affiliation_strings":["University of Bari Aldo Moro"],"raw_orcid":"https://orcid.org/0009-0007-2910-9359","affiliations":[{"raw_affiliation_string":"University of Bari Aldo Moro","institution_ids":["https://openalex.org/I5561750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051344464","display_name":"Luca Piemontese","orcid":"https://orcid.org/0000-0002-7980-5818","observed_orcids":["https://orcid.org/0000-0002-7980-5818"]},"institutions":[{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Luca Piemontese","raw_affiliation_strings":["University of Bari Aldo Moro"],"raw_orcid":"https://orcid.org/0000-0002-7980-5818","affiliations":[{"raw_affiliation_string":"University of Bari Aldo Moro","institution_ids":["https://openalex.org/I5561750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5051344464"],"corresponding_institution_ids":["https://openalex.org/I5561750"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.84008678,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":1.0},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.8949999809265137},{"id":"https://openalex.org/keywords/multi-target-drug-design","display_name":"multi-target drug design","score":0.7770000100135803},{"id":"https://openalex.org/keywords/molecular-hybrids","display_name":"molecular hybrids","score":0.7070000171661377},{"id":"https://openalex.org/keywords/rivastigmine","display_name":"rivastigmine","score":0.9430000185966492},{"id":"https://openalex.org/keywords/donepezil","display_name":"donepezil","score":1.0},{"id":"https://openalex.org/keywords/protein-misfolding","display_name":"protein misfolding","score":0.8119999766349792},{"id":"https://openalex.org/keywords/protein-aggregation","display_name":"protein aggregation","score":0.9039999842643738},{"id":"https://openalex.org/keywords/symptomatic-treatment","display_name":"symptomatic treatment","score":0.6620000004768372}],"concepts":[{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.46230000257492065},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4250999987125397},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41370001435279846},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.40860000252723694},{"id":"https://openalex.org/C12713177","wikidata":"https://www.wikidata.org/wiki/Q1900281","display_name":"Perspective (graphical)","level":2,"score":0.36959999799728394},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.357699990272522},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3499000072479248},{"id":"https://openalex.org/C2989108626","wikidata":"https://www.wikidata.org/wiki/Q904407","display_name":"Drug target","level":2,"score":0.3116999864578247},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.29510000348091125},{"id":"https://openalex.org/C168167062","wikidata":"https://www.wikidata.org/wiki/Q1117970","display_name":"Component (thermodynamics)","level":2,"score":0.2824000120162964},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.2816999852657318},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2754000127315521},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.274399995803833},{"id":"https://openalex.org/C3020580240","wikidata":"https://www.wikidata.org/wiki/Q663272","display_name":"Expert opinion","level":2,"score":0.26969999074935913},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2689000070095062},{"id":"https://openalex.org/C136238340","wikidata":"https://www.wikidata.org/wiki/Q7251455","display_name":"Protein aggregation","level":2,"score":0.26489999890327454},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.2623000144958496},{"id":"https://openalex.org/C2778012447","wikidata":"https://www.wikidata.org/wiki/Q1034415","display_name":"Scope (computer science)","level":2,"score":0.2549000084400177}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1080/17460441.2026.2749525","doi":"https://doi.org/10.1080/17460441.2026.2749525","is_oa":true,"landing_page_url":"https://doi.org/10.1080/17460441.2026.2749525","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/17460441.2026.2749525?needAccess=true","source":{"id":"https://openalex.org/S142541038","display_name":"Expert Opinion on Drug Discovery","issn_l":"1746-0441","issn":["1746-0441","1746-045X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Discovery","raw_type":"journal-article"},{"id":"pmid:42953958","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42953958","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on drug discovery","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/17460441.2026.2749525","doi":"https://doi.org/10.1080/17460441.2026.2749525","is_oa":true,"landing_page_url":"https://doi.org/10.1080/17460441.2026.2749525","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/17460441.2026.2749525?needAccess=true","source":{"id":"https://openalex.org/S142541038","display_name":"Expert Opinion on Drug Discovery","issn_l":"1746-0441","issn":["1746-0441","1746-045X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Discovery","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320323256","display_name":"Universita degli Studi di Bari Aldo Moro","ror":"https://ror.org/027ynra39"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224673567.pdf","grobid_xml":"https://content.openalex.org/works/W7224673567.grobid-xml"},"referenced_works_count":104,"referenced_works":["https://openalex.org/W1528685627","https://openalex.org/W1570813833","https://openalex.org/W1964869721","https://openalex.org/W1985026267","https://openalex.org/W2027955282","https://openalex.org/W2072826051","https://openalex.org/W2142587255","https://openalex.org/W2144075042","https://openalex.org/W2317110841","https://openalex.org/W2318190493","https://openalex.org/W2415147268","https://openalex.org/W2466838408","https://openalex.org/W2550503905","https://openalex.org/W2606010066","https://openalex.org/W2749929717","https://openalex.org/W2783328454","https://openalex.org/W2886819196","https://openalex.org/W2888930140","https://openalex.org/W2889134908","https://openalex.org/W2904170142","https://openalex.org/W2934170679","https://openalex.org/W2937150823","https://openalex.org/W2944155053","https://openalex.org/W2949937187","https://openalex.org/W2954109746","https://openalex.org/W2970537246","https://openalex.org/W2982693200","https://openalex.org/W2991652025","https://openalex.org/W3008645121","https://openalex.org/W3035889410","https://openalex.org/W3044446509","https://openalex.org/W3102529384","https://openalex.org/W3120211511","https://openalex.org/W3138887755","https://openalex.org/W3154034682","https://openalex.org/W3189293828","https://openalex.org/W3190494224","https://openalex.org/W3198094402","https://openalex.org/W3199985966","https://openalex.org/W3200955862","https://openalex.org/W3206321656","https://openalex.org/W4206046172","https://openalex.org/W4213249938","https://openalex.org/W4220995427","https://openalex.org/W4221124351","https://openalex.org/W4223999165","https://openalex.org/W4225670844","https://openalex.org/W4229057365","https://openalex.org/W4280527998","https://openalex.org/W4280575759","https://openalex.org/W4283522325","https://openalex.org/W4285023465","https://openalex.org/W4289337245","https://openalex.org/W4293016822","https://openalex.org/W4299551400","https://openalex.org/W4304690830","https://openalex.org/W4307968570","https://openalex.org/W4308008048","https://openalex.org/W4309008621","https://openalex.org/W4313481486","https://openalex.org/W4317632868","https://openalex.org/W4323358951","https://openalex.org/W4377029875","https://openalex.org/W4385333139","https://openalex.org/W4387393111","https://openalex.org/W4391883526","https://openalex.org/W4392013406","https://openalex.org/W4392352208","https://openalex.org/W4392714786","https://openalex.org/W4392925241","https://openalex.org/W4400061043","https://openalex.org/W4402573027","https://openalex.org/W4402760057","https://openalex.org/W4403527763","https://openalex.org/W4404724713","https://openalex.org/W4405831758","https://openalex.org/W4409572593","https://openalex.org/W4411413523","https://openalex.org/W4412181886","https://openalex.org/W4412517899","https://openalex.org/W4412832697","https://openalex.org/W4413117388","https://openalex.org/W4413621694","https://openalex.org/W4413913372","https://openalex.org/W4414069184","https://openalex.org/W4415647175","https://openalex.org/W4415987319","https://openalex.org/W4417178812","https://openalex.org/W7118161254","https://openalex.org/W7118192887","https://openalex.org/W7128372098","https://openalex.org/W7130958040","https://openalex.org/W7140175015","https://openalex.org/W7147679937","https://openalex.org/W7151433850","https://openalex.org/W7154902059","https://openalex.org/W7155224798","https://openalex.org/W7155857639","https://openalex.org/W7162035006","https://openalex.org/W7165917570","https://openalex.org/W7167901839","https://openalex.org/W7171497984","https://openalex.org/W7202072870","https://openalex.org/W7203472812"],"related_works":["https://openalex.org/W2914153178","https://openalex.org/W2949937187","https://openalex.org/W2103544616","https://openalex.org/W3212098840","https://openalex.org/W7214383467","https://openalex.org/W7202072870","https://openalex.org/W2536197083","https://openalex.org/W3086481192","https://openalex.org/W3199009864","https://openalex.org/W3087384679"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Alzheimer's":[1,130],"disease":[2],"(AD)":[3],"is":[4,50],"the":[5,25,39,54,87,133],"most":[6,26,42],"prevalent":[7],"neurodegenerative":[8],"disorder,":[9],"characterized":[10],"by":[11,91],"a":[12,73,126],"complex":[13],"and":[14,22,28,100,147],"multifactorial":[15],"etiology":[16],"that":[17],"complicates":[18],"its":[19],"diagnosis,":[20],"prevention,":[21],"treatment.":[23],"Among":[24],"historically":[27],"extensively":[29],"investigated":[30],"therapeutic":[31],"targets":[32],"are":[33],"cholinesterases":[34],"(ChEs),":[35],"which":[36],"have":[37,80,106],"guided":[38],"development":[40],"of":[41,56,95,103],"currently":[43],"available":[44],"symptomatic":[45,168],"drugs.":[46,118],"Consequently,":[47],"anti-ChE":[48,75],"activity":[49,158],"frequently":[51],"incorporated":[52],"into":[53],"design":[55,137],"potential":[57],"multi-target":[58,70],"anti-AD":[59,96],"compounds.":[60],"AREAS":[61],"COVERED:":[62],"This":[63],"critical":[64],"perspective":[65,128],"highlights":[66],"recent":[67],"advances":[68],"in":[69],"derivatives":[71],"with":[72,110,144],"central":[74],"property.":[76],"Various":[77],"structural":[78,93],"scaffolds":[79],"been":[81],"explored,":[82],"bearing":[83],"additive":[84],"properties":[85],"to":[86,138],"final":[88],"hybrids,":[89],"designed":[90],"combining":[92],"features":[94],"drugs":[97],"(namely":[98],"rivastigmine":[99],"donepezil).":[101],"Many":[102],"these":[104],"compounds":[105,139],"demonstrated":[107],"promising":[108,127],"outcomes,":[109],"some":[111],"exhibiting":[112],"greater":[113],"potency":[114],"than":[115],"their":[116],"reference":[117],"EXPERT":[119],"OPINION:":[120],"Multi-target":[121],"small-molecule":[122],"hybrids":[123],"may":[124],"represent":[125],"for":[129,167],"disease,":[131],"shifting":[132],"focus":[134],"from":[135],"cholinesterase-centered":[136],"primarily":[140],"aimed":[141],"at":[142],"interfering":[143],"protein":[145],"misfolding":[146],"aggregation,":[148],"as":[149,151],"well":[150],"other":[152],"targets.":[153],"In":[154],"this":[155],"framework,":[156],"anticholinesterase":[157],"would":[159],"remain":[160],"an":[161],"accessory":[162],"but":[163],"still":[164],"important":[165],"component":[166],"control.":[169]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-30T00:00:00"}